SI-BONE, Inc. Files Q1 2025 10-Q
Ticker: SIBN · Form: 10-Q · Filed: 2025-05-06T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
**SI-BONE Q1 2025 10-Q FILED: Financials and operations update.**
AI Summary
SI-BONE, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and strategic information relevant to investors and stakeholders are presented.
Why It Matters
This filing provides crucial insights into SI-BONE's financial health and operational progress during the first quarter of 2025, impacting investor decisions and market perception.
Risk Assessment
Risk Level: medium — As a medical device company, SI-BONE operates in a highly regulated industry with inherent product development, market adoption, and reimbursement risks.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-01-01 — Reporting Period Start Date (Indicates the beginning of the financial quarter being reported.)
- 2024-12-31 — Previous Year End Date (Provides a comparison point for financial performance.)
Key Players & Entities
- SI-BONE, Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250506 (date) — Filing date of the report
- 4082070700 (dollar_amount) — Business phone number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 6, 2025.
What is SI-BONE, Inc.'s primary industry classification?
SI-BONE, Inc. is classified under SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841].
What is the company's state of incorporation?
The company is incorporated in Delaware (DE).
What is the business address of SI-BONE, Inc.?
The business address is 471 El Camino Real, Suite 101, Santa Clara, CA 95050.
From the Filing
0001459839-25-000061.txt : 20250506 0001459839-25-000061.hdr.sgml : 20250506 20250506160551 ACCESSION NUMBER: 0001459839-25-000061 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250506 DATE AS OF CHANGE: 20250506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SI-BONE, Inc. CENTRAL INDEX KEY: 0001459839 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 262216351 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38701 FILM NUMBER: 25917212 BUSINESS ADDRESS: STREET 1: 471 EL CAMINO REAL, SUITE 101 CITY: SANTA CLARA STATE: CA ZIP: 95050 BUSINESS PHONE: 4082070700 MAIL ADDRESS: STREET 1: 471 EL CAMINO REAL, SUITE 101 CITY: SANTA CLARA STATE: CA ZIP: 95050 FORMER COMPANY: FORMER CONFORMED NAME: SI-Bone Inc. DATE OF NAME CHANGE: 20090326 10-Q 1 sibn-20250331.htm 10-Q sibn-20250331 0001459839 December 31 2025 Q1 false 1 1 http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent P1Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares sibn:segment xbrli:pure 0001459839 2025-01-01 2025-03-31 0001459839 2025-04-30 0001459839 2025-03-31 0001459839 2024-12-31 0001459839 2024-01-01 2024-03-31 0001459839 us-gaap:CommonStockMember 2024-12-31 0001459839 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001459839 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001459839 us-gaap:RetainedEarningsMember 2024-12-31 0001459839 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001459839 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001459839 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001459839 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001459839 us-gaap:CommonStockMember 2025-03-31 0001459839 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001459839 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001459839 us-gaap:RetainedEarningsMember 2025-03-31 0001459839 us-gaap:CommonStockMember 2023-12-31 0001459839 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001459839 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001459839 us-gaap:RetainedEarningsMember 2023-12-31 0001459839 2023-12-31 0001459839 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001459839 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001459839 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001459839 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001459839 us-gaap:CommonStockMember 2024-03-31 0001459839 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001459839 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001459839 us-gaap:RetainedEarningsMember 2024-03-31 0001459839 2024-03-31 0001459839 country:US 2025-01-01 2025-03-31 0001459839 country:US 2024-01-01 2024-03-31 0001459839 us-gaap:NonUsMember 2025-01-01 2025-03-31 0001459839 us-gaap:NonUsMember 2024-01-01 2024-03-31 0001459839 us-gaap:MoneyMarketFundsMember 2025-03-31 0001459839 us-gaap:USTreasurySecuritiesMember 2025-03-31 0001459839 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2025-03-31 0001459839 us-gaap:MoneyMarketFundsMember 2024-12-31 0001459839 us-gaap:USTreasurySecuritiesMember 2024-12-31 0001459839 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2024-12-31 0001459839 2024-01-01 2024-12-31 0001459839 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2025-03-31 0001459839 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2025-03-31 0001459839 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2025-03-31 0001459839 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFun